Polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome with dilated cardiomyopathy: A case report
- PMID: 38322456
- PMCID: PMC10841945
- DOI: 10.12998/wjcc.v12.i3.601
Polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome with dilated cardiomyopathy: A case report
Abstract
Background: Polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes (POEMS) syndrome is a rare paraneoplastic syndrome that encompass multiple systems. The most common clinical symptoms of POEMS syndrome are progressive sensorimotor polyneuropathy, organ enlargement, endocrine disorders, darkening skin, a monoclonal plasma cell proliferative disorder, and lymph node hyperplasia. The organomegaly consists of hepatosplenomegaly and/or lymphadenopathy; cases of cardiomyopathy are rare. Diagnoses are often delayed because of the atypical nature of the syndrome, exposing patients to possibly severe disability. Therefore, identifying atypical symptoms can improve the prognosis and quality of life among POEMS syndrome patients.
Case summary: Herein, we report the case of a 59-year-old woman with POEMS syndrome that involved dilated cardiomyopathy. The patient presented to the hospital with complaints of shortness of breath and discomfort in the chest. The patient reported previous experiences of limb numbness. During hospitalization, the brain natriuretic peptide levels were 3504.0 pg/mL. Color doppler echocardiography showed an enlarged left side of the heart, along with ventricular wall hypokinesis and compromised functioning of the same side of the heart. Abdominal color ultrasonography revealed that the patient's spleen was enlarged. Observations from cardiac magnetic resonance imaging showed that the left side of the heart was enlarged. Slight myocardical fibrosis was also observed. Electromyography was described as a symmetric sensorimotor demyelinating polyneuropathy. Further immunoelectrophoresis of the serum showed the presence of a monoclonal IGA λ M protein. The vascular endothelial growth factor levels were 622.56 pg/mL. Flow cytometric and immunohistochemical staining of the bone marrow detected no monoclonal plasma cells. Finally, the patient was diagnosed with POEMS syndrome associated with dilated cardiomyopathy. The chest-related discomfort and the shortness of breath resolved after the administration of lenalidomide and dexamethasone.
Conclusion: When patients with cardiomyopathy have systemic manifestations such as numb limbs and darkening skin, the POEMS syndrome is the most possible diagnosis.
Keywords: Case report; Dexamethasone; Dilated cardiomyopathy; Lenalidomide; M-protein; Polyneuropathy; endocrinopathy; organomegaly; skin changes syndrome.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
Figures
Similar articles
-
Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report.J Med Case Rep. 2019 Dec 27;13(1):384. doi: 10.1186/s13256-019-2309-z. J Med Case Rep. 2019. PMID: 31878962 Free PMC article.
-
Diagnostic Challenges of Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, and Skin Changes (POEMS) Syndrome: A Rare Case Report and Review of the Literature.Cardiovasc Hematol Disord Drug Targets. 2025 Mar 13. doi: 10.2174/011871529X352283250305042317. Online ahead of print. Cardiovasc Hematol Disord Drug Targets. 2025. PMID: 40143390
-
Living with Polyneuropathy Organomegaly Endocrinopathy Monoclonal gammopathy Skin changes (POEMS) syndrome: a case study of healthcare experiences and quality of life.Disabil Rehabil. 2021 Aug;43(17):2502-2510. doi: 10.1080/09638288.2019.1700563. Epub 2019 Dec 14. Disabil Rehabil. 2021. PMID: 31838877
-
Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.JAMA Oncol. 2021 Sep 1;7(9):1383-1391. doi: 10.1001/jamaoncol.2021.0586. JAMA Oncol. 2021. PMID: 34081097 Review.
-
POEMS syndrome with undetectable M-protein: a case report and literature review.Diagn Pathol. 2024 Jun 7;19(1):74. doi: 10.1186/s13000-024-01502-4. Diagn Pathol. 2024. PMID: 38849857 Free PMC article. Review.
Cited by
-
A case report of an M protein-negative patient with POEMS syndrome associated with renal involvement.BMC Nephrol. 2024 Dec 24;25(1):472. doi: 10.1186/s12882-024-03898-z. BMC Nephrol. 2024. PMID: 39719549 Free PMC article.
References
-
- Ali T, Qazilbash MH. POEMS syndrome: A multisystem clonal disorder. Eur J Haematol. 2021;106:14–18. - PubMed
-
- Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101:2496–2506. - PubMed
-
- Li J, Zhou DB, Huang Z, Jiao L, Duan MH, Zhang W, Zhao YQ, Shen T. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol. 2011;90:819–826. - PubMed
-
- Kulkarni GB, Mahadevan A, Taly AB, Yasha TC, Seshagiri KS, Nalini A, Satishchandra P, Veerendrakumar M, Shankar SK. Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome. J Clin Neurosci. 2011;18:356–360. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous